Elena Chiavacci

Dr. Elena Chiavacci

Biology, Scuola Normale Superiore di Pisa, Pisa, Tuscany, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Development
Verified
Journal Article
Open access
PDF file
ABAlexa Burger
Alexa Burger
HLHelen Lindsay
Helen Lindsay
AFAnastasia Felker
Anastasia Felker
CHChristopher Hess
Christopher Hess
CACarolin Anders
Carolin Anders
CMChristian Mosimann
Christian Mosimann
CRISPR-Cas9 enables efficient sequence-specific mutagenesis for creating somatic or germline mutants of model organisms. Key constraints in vivo remain the expression and delivery of active Cas9-guideRNA ribonucleoprotein complexes (RNPs) with minimal toxicity, variable mutagenesis efficiencies depending on targeting sequence, and high mutation mosaicism. Here, we apply in vitro-assembled, fluorescent Cas9-sgRNA RNPs in solubilizing salt solution to achieve maximal mutagenesis efficiency in zebrafish embryos. MiSeq-based sequence analysis of targeted loci in individual embryos using CrispRVariants, a customized software tool for mutagenesis quantification and visualization, reveals efficient bi-allelic mutagenesis that reaches saturation at several tested gene loci. Such virtually complete mutagenesis exposes loss-of-function phenotypes for candidate genes in somatic mutant embryos for subsequent generation of stable germline mutants. We further show that targeting of non-coding elements in gene-regulatory regions using saturating mutagenesis uncovers functional control elements in transgenic reporters and endogenous genes in injected embryos. Our results establish that optimally solubilized, in vitro assembled fluorescent Cas9-sgRNA RNPs provide a reproducible reagent for direct and scalable loss-of-function studies and applications beyond zebrafish experiments that require maximal DNA cutting efficiency in vivo.

12 July 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
HLHelen Lindsay
Helen Lindsay
ABAlexa Burger
Alexa Burger
BBBerthin Biyong
Berthin Biyong
AFAnastasia Felker
Anastasia Felker
CHChristopher Hess
Christopher Hess
MRMark D Robinson
Mark D Robinson

30 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAngela Meccariello
Angela Meccariello
Simona Maria MontiSimona Maria Monti
Simona Maria Monti
ARAlessandra Romanelli
Alessandra Romanelli
RCRita Colonna
Rita Colonna
PPPasquale Primo
Pasquale Primo
GSGiuseppe Saccone
Giuseppe Saccone
The Mediterranean fruitflyCeratitis capitata(medfly) is an invasive agricultural pest of high economic impact and has become an emerging model for developing new genetic control strategies as an alternative to insecticides. Here, we report the successful adaptation of CRISPR-Cas9-based gene disruption in the medfly by injectingin vitropre-assembled, solubilized Cas9 ribonucleoprotein complexes (RNPs) loaded with gene-specific single guide RNAs (sgRNA) into early embryos. When targeting the eye pigmentation genewhite eye(we), a high rate of somatic mosaicism in surviving G0 adults was observed. Germline transmission rate of mutatedwealleles by G0 animals was on average above 52%, with individual cases achieving nearly 100%. We further recovered large deletions in thewegene when two sites were simultaneously targeted by two sgRNAs. CRISPR-Cas9 targeting of theCeratitisortholog of theDrosophilasegmentationpairedgene (Ccprd) caused segmental malformations in late embryos and in hatched larvae. Mutant phenotypes correlate with repair by non-homologous end-joining (NHEJ) lesions in the two targeted genes. This simple and highly effective Cas9 RNP-based gene editing to introduce mutations inC. capitatawill significantly advance the design and development of new effective strategies for pest control management.

30 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ECElena Chiavacci
Elena Chiavacci
LDLuca Dolfi
Luca Dolfi
LVLorena Verduci
Lorena Verduci
FMFrancesco Meghini
Francesco Meghini
GGGaia Gestri
Gaia Gestri
Letizia PittoLetizia Pitto
Letizia Pitto
tbx5, a member of the T-box gene family, encodes one of the key transcription factors mediating vertebrate heart development. Tbx5 function in heart development appears to be exquisitely sensitive to gene dosage, since both haploinsufficiency and gene duplication generate the cardiac abnormalities associated with Holt−Oram syndrome (HOS), a highly penetrant autosomal dominant disease characterized by congenital heart defects of varying severity and upper limb malformation. It is suggested that tight integration of microRNAs and transcription factors into the cardiac genetic circuitry provides a rich and robust array of regulatory interactions to control cardiac gene expression. Based on these considerations, we performed an in silico screening to identify microRNAs embedded in genes highly sensitive to Tbx5 dosage. Among the identified microRNAs, we focused our attention on miR-218-1 that, together with its host gene, slit2, is involved in heart development. We found correlated expression of tbx5 and miR-218 during cardiomyocyte differentiation of mouse P19CL6 cells. In zebrafish embryos, we show that both Tbx5 and miR-218 dysregulation have a severe impact on heart development, affecting early heart morphogenesis. Interestingly, down-regulation of miR-218 is able to rescue the heart defects generated by tbx5 over-expression supporting the notion that miR-218 is a crucial mediator of Tbx5 in heart development and suggesting its possible involvement in the onset of heart malformations.

26 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
KPKarin D. Prummel
Karin D. Prummel
CHChristopher Hess
Christopher Hess
SNSusan Nieuwenhuize
Susan Nieuwenhuize
HPHugo Parker
Hugo Parker
KRKatherine W. Rogers
Katherine W. Rogers
CMChristian Mosimann
Christian Mosimann
Cardiovascular lineages develop together with kidney, smooth muscle, and limb connective tissue progenitors from the lateral plate mesoderm (LPM). How the LPM initially emerges and how its downstream fates are molecularly interconnected remain unknown. Here, we isolate a pan-LPM enhancer in the zebrafish-specific draculin (drl) gene that provides specific LPM reporter activity from early gastrulation. In toto live imaging and lineage tracing of drl-based reporters captures the dynamic LPM emergence as lineage-restricted mesendoderm field. The drl pan-LPM enhancer responds to the transcription factors EomesoderminA, FoxH1, and MixL1 that combined with Smad activity drive LPM emergence. We uncover specific activity of zebrafish-derived drl reporters in LPM-corresponding territories of several chordates including chicken, axolotl, lamprey, Ciona, and amphioxus, revealing a universal upstream LPM program. Altogether, our work provides a mechanistic framework for LPM emergence as defined progenitor field, possibly representing an ancient mesodermal cell state that predates the primordial vertebrate embryo.

26 October 2018 in Genes & Development
Verified
Journal Article
Open access
PDF file
CCClaudio Cantù
Claudio Cantù
AFAnastasia Felker
Anastasia Felker
DZDario Zimmerli
Dario Zimmerli
KPKarin D. Prummel
Karin D. Prummel
ECElena M. Cabello
Elena M. Cabello
CMChristian Mosimann
Christian Mosimann
Bcl9 and Pygopus (Pygo) are obligate Wnt/β-catenin cofactors in Drosophila , yet their contribution to Wnt signaling during vertebrate development remains unresolved. Combining zebrafish and mouse genetics, we document a conserved, β-catenin-associated function for BCL9 and Pygo proteins during vertebrate heart development. Disrupting the β-catenin–BCL9–Pygo complex results in a broadly maintained canonical Wnt response yet perturbs heart development and proper expression of key cardiac regulators. Our work highlights BCL9 and Pygo as selective β-catenin cofactors in a subset of canonical Wnt responses during vertebrate development. Moreover, our results implicate alterations in BCL9 and BCL9L in human congenital heart defects.